Anuj K.
About Anuj K.
Anuj K. serves as the Senior Director of Oncology, Pharmaceutical Affairs & Partnerships at OPKO Health, Inc. He has over 19 years of experience in oncology and pharmaceuticals, with a strong focus on artificial intelligence and digital pathology applications in cancer diagnostics.
Work at OPKO Health
Anuj K. serves as the Senior Director of Oncology, Pharmaceutical Affairs & Partnerships at OPKO Health, Inc. He has held this position since 2023. In this role, he focuses on strategic initiatives within the oncology sector, leveraging his extensive experience in pharmaceutical affairs and partnerships to drive business objectives.
Previous Experience in Oncology and Pharmaceuticals
Anuj K. has a diverse background in oncology and pharmaceuticals. He worked at Novartis Institutes for BioMedical Research as a Project Leader from 2013 to 2015 and at Regeneron Pharmaceuticals, Inc. as an R&D Lead from 2016 to 2018. His experience also includes roles at Massachusetts General Hospital and Precision Medicine Group, where he contributed to various oncology and targeted therapies projects.
Education and Expertise
Anuj K. possesses extensive knowledge in digital pathology and its applications in cancer diagnostics. He has a comprehensive understanding of both germ-line and somatic genomics, which aligns with current industry growth strategies. His expertise extends to leveraging artificial intelligence to improve patient outcomes in healthcare and the pharmaceutical industry.
Background in Research and Clinical Roles
Anuj K. has a strong research background, having worked at Harvard Medical School in various capacities from 2004 to 2016. His roles included Clinical & Research Specialist and Sr. Researcher Oncology Specialist. This experience has provided him with a solid foundation in clinical oncology and targeted therapies.
Leadership and Team Development
Anuj K. is known for nurturing teams and championing growth within the oncology and pharmaceutical sectors. He emphasizes a customer-centric focus and strategic agility, driving results through business acumen. His leadership style promotes collaboration and innovation, essential for achieving desired outcomes in complex environments.